Page last updated: 2024-09-03

ro 43-5054 and Coronary Disease

ro 43-5054 has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hadváry, P; Kuhn, H; Roux, SP; Steiner, B; Tschopp, TB	1

Other Studies

1 other study(ies) available for ro 43-5054 and Coronary Disease

Article	Year
Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:1 Topics: Amino Acid Sequence; Animals; Aspirin; Bleeding Time; Coronary Disease; Coronary Vessels; Dogs; Female; Hemodynamics; Heparin; Male; Molecular Sequence Data; Myocardial Reperfusion; Oligopeptides; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Rabbits; Receptors, Immunologic; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator	1993

Article

Year

Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.

The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:1

Topics: Amino Acid Sequence; Animals; Aspirin; Bleeding Time; Coronary Disease; Coronary Vessels; Dogs; Female; Hemodynamics; Heparin; Male; Molecular Sequence Data; Myocardial Reperfusion; Oligopeptides; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Rabbits; Receptors, Immunologic; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator

1993